Abstract:Yongwei Gu, 1– 3, * Qing Gu, 4, * Qing Yang, 1, 2 Meng Yang, 3 Shengzhang Wang, 5 Jiyong Liu 1– 3 1 Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China; 3 Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China; 4 Department of Pharmacy, Jingan District Zhabei Central Hospital, Shanghai 200070, People's Republic of China; 5 Institute of Biomechanics, Department of Aeronautics and Astronautics, Fudan University, Shanghai 200433, People's Republic of China *These authors contributed equally to this work Correspondence: Shengzhang Wang Department of Aeronautics and Astronautics, Institute of Biomechanics, Fudan University, Shanghai 200433, People's Republic of China Tel/Fax +86-21-65647825 Email szwang@fudan.edu.cn Jiyong Liu Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China Tel/Fax +86-21-64175590 Email liujiyong@fudan.edu.cn Background: Skin pharmacokinetics is an indispensable indication for studying the drug fate after administration of transdermal drug delivery systems (TDDS). However, the heterogeneity and complex skin structured with stratum corneum, viable epidermis, dermis, and subcutaneous tissue inevitably leads the drug diffusion coefficient ( K p) to vary depending on the skin depth, which seriously limits the development of TDDS pharmacokinetics in full thickness skin. Methods: A multilayer geometry skin model was established and the K p of drug in SC, viable epidermis, and dermis was obtained using the technologies of molecular dynamics simulation, in vitro permeation experiments, and in vivo microdialysis, respectively. Besides, finite element analysis (FEA) based on drug K ps in different skin layers was applied to simulate the paeonol nanoemulsion (PAE-NEs) percutaneous dynamic penetration process in two and three dimensions. In addition, PAE-NEs skin pharmacokinetics profile obtained by the simulation was verified by in vivo experiment. Results: Coarse-grained modeling of molecular dynamic simulation was successfully established and the K p of PAE in SC was 2.00× 10 − 6 cm 2 /h. The K p of PAE-NE in viable epidermis and in dermis detected using penetration test and microdialysis probe technology, was 1.58× 10 − 5 cm 2 /h and 3.20× 10 − 5 cm 2 /h, respectively. In addition, the results of verification indicated that PAE-NEs skin pharmacokinetics profile obtained by the simulation was consistent with that by in vivo experiment. Discussion: This study demonstrated that the FEA combined with the established multilayer geometry skin model could accurately predict the skin pharmacokinetics of TDDS. Keywords: nano transdermal drug delivery system, skin pharmacokinetics, finite element analysis, multilayer geometry model, diffusion coefficient, paeonol nanoemulsion

PREDICTING SKIN PERMEABILITY OF DRUGS WITH THEORETICAL PARAMETERS

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals

An evaluation of mathematical models for predicting skin permeability.

Limitation of Potts and Guy's model and a predictive algorithm for skin permeability including the effects of hydrogen-bond on diffusivity

Artificial intelligence for skin permeability prediction: deep learning

Predictive modeling of skin permeability for molecules: Investigating FDA-approved drug permeability with various AI algorithms

Quantitative structure-activity relationships for skin permeability

Modeling Transdermal Permeation. Part I. Predicting Skin Permeability of Both Hydrophobic and Hydrophilic Solutes

Recent advances in predicting skin permeability of hydrophilic solutes.

Evaluating Molecular Properties Involved in Transport of Small Molecules in Stratum Corneum: A Quantitative Structure-Activity Relationship for Skin Permeability

Finite Element Analysis for Predicting Skin Pharmacokinetics of Nano Transdermal Drug Delivery System Based on the Multilayer Geometry Model

Quantitative Retention‐Activity Relationship Studies by Liposome Electrokinetic Chromatography to Predict Skin Permeability

Comparative QSPR modeling of skin permeability for organic compounds using stepwise-MLR and PLS

Modeling Transdermal Permeation. Part 2. Predicting the Dermatopharmacokinetics of Percutaneous Solute

Prediction of Drug Permeation Through Microneedled Skin by Machine Learning

Assessment of skin permeability to topically applied drugs by skin impedance and admittance

Application of RP-18 TLC Retention Data to the Prediction of the Transdermal Absorption of Drugs

Percutaneous absorption of steroids from finite doses: Predicting urinary excretion from in vitro skin permeation testing

A corneal-PAMPA-based in silico model for predicting corneal permeability

Prediction of Human Absorption of Natural Compounds by the Non-Everted Rat Intestinal Sac Model